Accelerated TMS to treat depression or OCD
Part of Mental health clinical trials.
This trial tests an “accelerated” form of transcranial magnetic stimulation (TMS) to reduce symptoms of depression or obsessive-compulsive disorder (OCD). You may be considered if standard treatments didn’t help (or you couldn’t tolerate them), and if it’s safe for you to receive TMS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have either major depression or OCD diagnosed by standard criteria
- Your symptoms are at least a certain severity level on approved rating scales
- You tried at least one standard first treatment before (or couldn’t take it due to reasons like side effects or not tolerating exposure therapy)
- You’re either not taking antidepressants, or you’ve been on a stable dose for at least 4 weeks (with a plan to keep the same dose during the study)
- You can give informed consent
- You do not have major safety blockers to TMS, based on screening (for example, certain brain/metal/health risks)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an accelerated form of TMS (a treatment that uses magnetic pulses to stimulate the brain) for people with severe depression who have recently been in a psychiatric hospital. It aims to see if a faster schedule of TMS can help improve symptoms quickly.
This trial tests a new type of transcranial magnetic stimulation (TMS) for people with severe depression that hasn't improved with multiple medications or therapy. It uses a different frequency pattern to target brain circuits.
This trial tests a new way to use magnetic pulses to target specific brain areas linked to depression. It aims to improve mood by stimulating a circuit that may be overactive in people with major depression.
This study tests whether a brain stimulation technique called TMS can help people with depression, anxiety, OCD, or schizophrenia. It aims to find better ways to target the treatment for each person's specific needs.
This trial tests an accelerated form of transcranial magnetic stimulation (TMS) for people with treatment-resistant depression who have been referred for ECT. It aims to offer a non-invasive, less intensive alternative with fewer side effects.
This study tests a noninvasive treatment called transcranial magnetic stimulation (TMS), which uses magnetic pulses to stimulate brain areas involved in depression. It is for adults with major depression that hasn't improved with medication.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.